- Home
- OBIO vs AEYE Comparison
OBIO vs AEYE Comparison
Compare OBIO & AEYE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OBIO
- AEYE
- Stock Information
- Founded
- OBIO 2017
- AEYE 2005
- Country
- OBIO United States
- AEYE United States
- Employees
- OBIO N/A
- AEYE N/A
- Industry
- OBIO Medicinal Chemicals and Botanical Products
- AEYE Computer Software: Prepackaged Software
- Sector
- OBIO Health Care
- AEYE Technology
- Exchange
- OBIO Nasdaq
- AEYE Nasdaq
- Market Cap
- OBIO 151.3M
- AEYE 138.0M
- IPO Year
- OBIO N/A
- AEYE N/A
- Fundamental
- Price
- OBIO $2.65
- AEYE $12.46
- Analyst Decision
- OBIO Strong Buy
- AEYE Strong Buy
- Analyst Count
- OBIO 5
- AEYE 5
- Target Price
- OBIO $14.20
- AEYE $26.40
- AVG Volume (30 Days)
- OBIO 959.6K
- AEYE 117.6K
- Earning Date
- OBIO 05-16-2025
- AEYE 04-29-2025
- Dividend Yield
- OBIO N/A
- AEYE N/A
- EPS Growth
- OBIO N/A
- AEYE N/A
- EPS
- OBIO N/A
- AEYE N/A
- Revenue
- OBIO $2,638,000.00
- AEYE $36,851,000.00
- Revenue This Year
- OBIO $13.87
- AEYE $20.29
- Revenue Next Year
- OBIO $32.19
- AEYE $18.65
- P/E Ratio
- OBIO N/A
- AEYE N/A
- Revenue Growth
- OBIO N/A
- AEYE 16.52
- 52 Week Low
- OBIO $2.43
- AEYE $8.91
- 52 Week High
- OBIO $8.87
- AEYE $34.85
- Technical
- Relative Strength Index (RSI)
- OBIO 43.61
- AEYE 56.11
- Support Level
- OBIO $2.37
- AEYE $11.17
- Resistance Level
- OBIO $2.99
- AEYE $12.60
- Average True Range (ATR)
- OBIO 0.33
- AEYE 1.05
- MACD
- OBIO 0.05
- AEYE 0.12
- Stochastic Oscillator
- OBIO 32.18
- AEYE 91.08
About OBIO Orchestra BioMed Holdings Inc.
Orchestra BioMed Holdings Inc is a biomedical innovation company accelerating high-impact technologies to patients through risk-reward sharing partnerships. Its partnership-enabled business model focuses on forging strategic collaborations with medical device companies to drive the global commercialization of the products it develops. The company's flagship product candidates include BackBeat Cardiac Neuromodulation Therapy (CNT) for the treatment of hypertension and Virtue Sirolimus AngioInfusionBalloon (SAB) for the treatment of atherosclerotic artery disease.
About AEYE AudioEye Inc.
AudioEye Inc is a software solution provider delivering immediate ADA and WCAG accessibility compliance at scale. Through patented technology, subject matter expertise and proprietary processes, it is eradicating all barriers to digital accessibility, helping creators get accessible and supporting them with ongoing advisory and automated upkeep. Trusted by the ADP, Tommy Hilfiger, A360 Media, Samsung, Landry's and others. It helps everyone identify and resolve issues of accessibility and enhance user experiences, automating digital accessibility for the widest audiences.